| 000 | 01243 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516200715.0 | ||
| 264 | 0 | _c20141103 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1399-5618 | ||
| 024 | 7 |
_a10.1111/bdi.12135 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarlinge, Emeline | |
| 245 | 0 | 0 |
_aWhite matter alterations in bipolar disorder: potential for drug discovery and development. _h[electronic resource] |
| 260 |
_bBipolar disorders _cMar 2014 |
||
| 300 |
_a97-112 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBipolar Disorder _xdrug therapy |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aCorpus Callosum _xpathology |
| 650 | 0 | 4 |
_aDatabases, Factual _xstatistics & numerical data |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNerve Fibers, Myelinated _xpathology |
| 700 | 1 | _aBellivier, Frank | |
| 700 | 1 | _aHouenou, Josselin | |
| 773 | 0 |
_tBipolar disorders _gvol. 16 _gno. 2 _gp. 97-112 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bdi.12135 _zAvailable from publisher's website |
| 999 |
_c23587438 _d23587438 |
||